Further, pharmacologic inhibition of MMP-9 in HTC cells dose-dependently reduced insulin-stimulated NEU1 sialidase activity, and treatment of NEU1-deficient human fibroblasts with olanzapine, an antipsychotic drug associated with insulin resistance, increased NEU3 sialidase activity, both compared with vehicle controls. The gene discussed is NEU3; the disease is Insulin resistance.